These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8533232)

  • 41. Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials.
    Makoschey B; Sonnemans D; Bielsa JM; Franken P; Mars M; Santos L; Alvarez M
    Vaccine; 2007 Aug; 25(32):6140-5. PubMed ID: 17336433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Foetal protection against bovine virus diarrhoea virus after two-step vaccination.
    Frey HR; Eicken K; Grummer B; Kenklies S; Oguzoglu TC; Moennig V
    J Vet Med B Infect Dis Vet Public Health; 2002 Dec; 49(10):489-93. PubMed ID: 12485359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bovine maternal, fetal and neonatal responses to bovine viral diarrhea virus infections.
    Kelling CL; Topliff CL
    Biologicals; 2013 Jan; 41(1):20-5. PubMed ID: 23084809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of Fetal Protection against Bovine Viral Diarrhea Virus in a Vaccinated Heifer.
    Klimowicz-Bodys MD; Polak MP; Płoneczka-Janeczko K; Bagnicka E; Zbroja D; Rypuła K
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new inactivated BVDV genotype I and II vaccine. An immunisation and challenge study with BVDV genotype I.
    Beer M; Hehnen HR; Wolfmeyer A; Poll G; Kaaden OR; Wolf G
    Vet Microbiol; 2000 Nov; 77(1-2):195-208. PubMed ID: 11042413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
    Fairbanks K; Schnackel J; Chase CC
    Vet Ther; 2003; 4(1):24-34. PubMed ID: 12756633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunological responses to bovine virus diarrhoea virus infections.
    Howard CJ
    Rev Sci Tech; 1990 Mar; 9(1):95-103. PubMed ID: 1966728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of fetal infection in heifers challenged with bovine viral diarrhoea virus type 1a by vaccination with a type 1c or type 1a vaccine.
    Packianathan R; Clough WJ; Hodge A; Holz DK; Huang J; Bryant GL; Colantoni C
    N Z Vet J; 2017 May; 65(3):134-139. PubMed ID: 28359226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of maternal antibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves.
    Ellis J; West K; Cortese V; Konoby C; Weigel D
    J Am Vet Med Assoc; 2001 Aug; 219(3):351-6. PubMed ID: 11497051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
    Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BVDV vaccination in North America: risks versus benefits.
    Griebel PJ
    Anim Health Res Rev; 2015 Jun; 16(1):27-32. PubMed ID: 26050569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b.
    Leyh RD; Fulton RW; Stegner JE; Goodyear MD; Witte SB; Taylor LP; Johnson BJ; Step DL; Ridpath JF; Holland BP
    Am J Vet Res; 2011 Mar; 72(3):367-75. PubMed ID: 21355740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Virus neutralising antibodies against 22 bovine viral diarrhoea virus isolates in vaccinated calves.
    Hamers C; Di Valentin E; Lecomte C; Lambot M; Joris E; Genicot B; Pastoret PP
    Vet J; 2002 Jan; 163(1):61-7. PubMed ID: 11749137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Humoral immune response and assessment of vaccine virus shedding in calves receiving modified live virus vaccines containing bovine herpesvirus-1 and bovine viral diarrhoea virus 1a.
    Fulton RW; Saliki JT; Burge LJ; Payton ME
    J Vet Med B Infect Dis Vet Public Health; 2003 Feb; 50(1):31-7. PubMed ID: 12710498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
    Xue W; Mattick D; Smith L
    Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of species and subgenotypes of bovine viral diarrhea virus on control by vaccination.
    Fulton RW
    Anim Health Res Rev; 2015 Jun; 16(1):40-54. PubMed ID: 26050571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
    Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
    Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2.
    Makoschey B; Janssen MG; Vrijenhoek MP; Korsten JH; Marel P
    Vaccine; 2001 Apr; 19(23-24):3261-8. PubMed ID: 11312023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the efficacy of a modified-live combination vaccine against bovine viral diarrhea virus types 1 and 2 challenge exposures in a one-year duration-of-immunity fetal protection study.
    Ficken MD; Ellsworth MA; Tucker CM
    Vet Ther; 2006; 7(3):283-94. PubMed ID: 17039451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins.
    Rosas CT; König P; Beer M; Dubovi EJ; Tischer BK; Osterrieder N
    J Gen Virol; 2007 Mar; 88(Pt 3):748-757. PubMed ID: 17325347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.